Lupus-Relevant Recovery Act Awards

Several NIH Recovery Act Awards announced in early June are targeted at small businesses and for-profit biotechnology companies—and may be of interest to R&D companies working in lupus. Others are relevant to lupus research in different and creative ways.

They include:

Small Business Catalyst Awards for Accelerating Innovative Research (R43)

This program invites grant applications from small business concerns that propose to accelerate innovation through high-risk, high-reward research and development that has commercial potential and is relevant to the mission of the NIH.

Entrepreneurs of exceptional creativity, drawn from scientific and technological environments beyond NIH, are invited to propose pioneering and possibly transformative approaches to addressing major biomedical or behavioral challenges with the potential for downstream commercial development.

Applications are due September 1, 2009.


Protection of Human Health by Immunology and Vaccines (U01, U19)

This program seeks to create a network of “human immunology profiling” research groups.

Applications are sought that study human immune responses

  • following infection
  • prior to and following vaccination against an infectious disease or prior to and following treatment with an immune adjuvant.

NIAID intends to commit approximately $20 million in total costs (direct plus indirect costs) in fiscal year 2010.

Proposals are due October 15, 2009.


Biomedical Research, Development, and Growth to Spur the Acceleration of New Technologies (BRDG-SPAN) Pilot Program (RC3)

This pilot program addresses the funding gap between promising research and development—and transitioning to the market—by contributing critical funding for the next appropriate milestone toward ultimate commercialization; i.e., to carry out later stage research activities necessary to that end.

It aims to accelerate the transition of research innovations and technologies to the development of products or services that will improve human health, help advance the mission of NIH, and create significant value and economic stimulus.

Another goal is to foster partnerships among a variety of research and development collaborators working toward these aims.

Applications are due September 1, 2009.


Academic Research Enhancement Award (R15)

This program strives to stimulate research in educational institutions that provide baccalaureate or advanced degrees for a significant number of the nation's research scientists—but which haven’t yet received major NIH support.

Up to 50 awards may be made in FY 2010. Applicants may request up to a total of $300,000 direct costs plus applicable indirect costs.

Proposals are due September 24, 2009.